menu
About Us
Classes Of Business
HMO Reinsurance
Provider Excess Of Less
Medical Reinsurance
Employer Stop Loss
Client Captive Programs
Cell & Gene Therapy
Cost Containment
News
Contact Us
News
Novartis’ Kymriah fails to meet primary goal in non-Hodgkin lymphoma trial
on
August 31, 2021
(updated September 1, 2021)
| Category:
News
Novartis’ Kymriah fails to meet primary goal in non-Hodgkin lymphoma trial
Click here to download PDF
